MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ancard.2018.09.012

Медицинская библиотека · Annales de cardiologie et d'angeiologie · 2018

[ST elevation myocardial infarction in young adults: Is there an interest for thrombophilia screening?].

Spagnoli V, Diefenbronn M, Merat B, Logeart D, Sideris G, Henry P, Manzo-Silberman S, Drouet L, Dillinger J G

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Coronary lesions characteristics as well as patient thrombogenicity can explain coronary events manifestation. In young patient, local conditions are usually less important and thrombogenicity could play a significant role. Assessing thrombophilia could be justified in young patients and may induce an adapted therapeutic management.

PURPOSE: We aimed to assess the prevalence of thrombophilia and therapeutic modification in young adults aged≤55 years admitted in our department for ST elevation myocardial infarction (STEMI).

METHODS

From January 2013 to January 2017, data on all patients aged≤55 years with STEMI admitted in emergency were retrospectively retrieved from our database. Thrombophilia investigation was made regarding clinical (with or without cardiovascular risk factors [CVRF]), biological and/or angiographic evaluation.

RESULTS

A total of 133 patients aged≤55 years with STEMI were included. Cardiac arrest occurred in 15 patients (11%). One or less CVRF were found in 47 patients (35%). Smoking was reported in 93 patients (70%) and drug addiction (cannabis, cocaine) in 19 patients (14%). A subset of 51 patients (38%) were screened for thrombophilia. Patients with thrombophilia assessment were younger, less active smokers and presented less CVRF than patients without investigation (P<0.001). Single vessel diseased was found in 88 patients (66%). No differences regarding coronary procedural characteristic were found between the two groups. The most frequently encountered aetiology, found in 122 patients (92%), was de novo intra-arterial thrombosis related to atherosclerosis. In patients with thrombophilia assessment (n=51), one or more abnormal biological results was found in 22 patients (43%) and a therapeutic adjustment was made in 6 patients (12%).

CONCLUSION

Thrombophilia screening in young STEMI adults showed an abnormality in 43% of cases. Antithrombotic treatment can be modified after its demonstration.

Для цитирования: Spagnoli V, Diefenbronn M, Merat B, Logeart D, Sideris G, Henry P, Manzo-Silberman S, Drouet L, Dillinger J G. [ST elevation myocardial infarction in young adults: Is there an interest for thrombophilia screening?].. Annales de cardiologie et d'angeiologie. 2018. DOI: 10.1016/j.ancard.2018.09.012.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.